Why Amphastar Pharmaceuticals (AMPH) Shares Are Sliding Today [Yahoo! Finance]
Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q4 Earnings? [Yahoo! Finance]
Amphastar Pharmaceuticals (AMPH) had its "hold" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $22.00 price target on the stock.
Amphastar Pharmaceuticals Highlights Baqsimi Milestones, Primatene Growth at Needham Conference [Yahoo! Finance]
Amphastar Pharmaceuticals (AMPH) was downgraded by
Weiss Ratings from "hold (c-)" to "sell (d+)".